NCT03407118View on ClinicalTrials.gov

A Study of LY900014 in Japanese Participants With Type 1 Diabetes Mellitus

PHASE1CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

February 17, 2018

Primary Completion Date

June 23, 2018

Study Completion Date

July 12, 2018

Conditions
Diabetes Mellitus, Type 1
Interventions
DRUG

LY900014

Administered SC.

DRUG

Insulin Lispro

Administered SC.

Trial Locations (1)

812-0025

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician., Fukuoka

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT03407118 - A Study of LY900014 in Japanese Participants With Type 1 Diabetes Mellitus | Biotech Hunter | Biotech Hunter